5.STOCK-BASED COMPENSATION



Stock-based compensation is recorded at fair value as of the date of grant, is included in the salaries and benefits expense line item on the consolidated statements of operations and amounted to $352,000 and $314,000 for the years ended December 31, 2017 and 2016, respectively. 



Stock Options:



The Company’s 1994 Stock Plan (the “Plan”) provides for the granting of awards in the form of stock options, restricted stock, stock appreciation rights, and deferred stock to key employees and non-employees, including directors of and consultants to the Company and any subsidiary, to purchase up to a maximum of 1,650,000 shares of common stock.  The Company currently has 389,486 shares available for grant under the Plan.  The Plan is administered by the Board of Directors which determines the persons who are to receive awards under the Plan, the type of award to be granted, the number of shares subject to each award and, if an option, the exercise price of each option. 



The Plan provides that payment of the exercise price may be made in the form of unrestricted shares of common stock already owned by the optionee. The Company calculates the fair market value of unrestricted shares as the average of the high and low sales prices on the date of the option exercise. The Company’s common stock is purchased upon the exercise of stock options, and restricted stock awards are settled in shares of the Company’s common stock.



Stock option activity related to the Plan during the years ended December 31, 2017 and 2016 is summarized below:





 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

2017

 

2016



 

 

 

Weighted

 

 

 

Weighted



 

 

 

Average

 

 

 

Average



 

Number of

 

Exercise

 

Number of

 

Exercise



 

Shares

 

Price

 

Shares

 

Price



 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at beginning of year

 

 

191,002 

 

$

9.08 

 

 

223,002 

 

$

9.30 



 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 -

 

 

 -

 

 

 -

 

 

 -

Exercised

 

 

(23,500)

 

 

7.75 

 

 

(2,000)

 

 

7.14 

Expired/Forfeited

 

 

(25,000)

 

 

11.11 

 

 

(30,000)

 

 

14.43 



 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at end of year

 

 

142,502 

 

$

8.19 

 

 

191,002 

 

$

9.08 



 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at end of year

 

 

142,502 

 

$

8.19 

 

 

191,002 

 

$

9.08 



The grant-date fair value of options outstanding and exercisable at December 31, 2017 and 2016 was $407,000 and $547,000, respectively.  The weighted average remaining contractual term of these options is 1.8 years.    



There were no options granted in 2017 or 2016.  The total fair value of options exercised during the years ended December 31, 2017 and 2016 was $58,000 and $4,900, respectively. The total intrinsic value of options exercised during 2017 and 2016 was $90,000 and $8,000, respectively.



The following table summarizes information concerning all options outstanding and options exercisable as of December 31, 2017:













 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

Options Outstanding

 

Options Exercisable



 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 



 

 

 

 

Average

 

 

Average

 

 

Aggregate

 

 

 

 

Average

 

 

Aggregate

Range of

 

Number

 

Life (Years)

 

 

Exercise

 

 

Intrinsic

 

Number

 

 

Exercise

 

 

Intrinsic

Exercise Price

 

Outstanding

 

Remaining

 

 

Price

 

 

Value

 

Exercisable

 

 

Price

 

 

Value

$

6.00 - 8.00

 

61,752 

 

1.4 

 

$

6.25 

 

$

617,568 

 

61,752 

 

$

6.25 

 

$

617,568 

$

8.01 - 11.00

 

53,750 

 

2.2 

 

$

8.28 

 

 

428,388 

 

53,750 

 

$

8.28 

 

 

428,388 

$

11.01 - 14.00

 

27,000 

 

1.8 

 

$

12.43 

 

 

103,050 

 

27,000 

 

$

12.43 

 

 

103,050 



Total

 

142,502 

 

1.8 

 

$

8.19 

 

$

1,149,006 

 

142,502 

 

$

8.19 

 

$

1,149,006 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Board of Directors Stock Option and Restricted Stock Grants



The Company’s Stock Plan was amended to authorize annual grants to non-employee members of the Board of Directors of restricted stock or stock options, or both, as determined by the BoardOptions granted under the Plan generally expire 10 years after the grant date and generally become exercisable over a four year period. Generally the restricted stock vests 100% after one year and is subject to restrictions on resale for an additional year. 



Restricted stock awards are subject to forfeiture if a board member terminates prior to the shares vesting. A summary of changes in Board of Directors unvested restricted stock as December 31, 2017:





 

 

 

 

 

 



 

 

 

 

Weighted



 

 

 

 

Average



 

Restricted

 

Fair Value



 

Stock

 

Per Share

Non-Vested Balance, December 31, 2015

 

 

13,940 

 

$

10.76 

  Granted

 

 

14,410 

 

 

10.41 

  Vested

 

 

(13,940)

 

 

10.76 

  Forfeited

 

 

 -

 

 

 -

Non-Vested Balance, December 31, 2016

 

 

14,410 

 

$

10.41 

  Granted

 

 

11,264 

 

 

10.65 

  Vested

 

 

(14,410)

 

 

10.41 

  Forfeited

 

 

 -

 

 

 -

Non-Vested Balance, December 31, 2017

 

 

11,264 

 

$

10.65 



 

 

 

 

 

 



Employee Deferred Stock Award Grants



Employee deferred stock awards are subject to forfeiture if an employee terminates prior to the vesting. Generally, the awards vest ratably over a four-year period and compensation costs are recognized over the vesting period. Compensation costs are recorded in “Salaries and benefits” on the Consolidated Statements of Operations. 



A summary of the changes in employee unvested deferred stock award grants as of December 31, 2017, is as follows:



 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

Weighted



 

 

 

 

Average



 

Deferred

 

Fair Value



 

Stock

 

Per Share

Non-Vested Balance, December 31, 2015

 

 

23,875 

 

$

10.31 

  Granted

 

 

 -

 

 

 -

  Vested

 

 

(11,875)

 

 

10.15 

  Forfeited

 

 

(2,500)

 

 

 -

Non-Vested Balance, December 31, 2016

 

 

9,500 

 

$

10.46 

  Granted

 

 

 -

 

 

 -

  Vested

 

 

(4,375)

 

 

10.46 

  Forfeited

 

 

 -

 

 

 -

Non-Vested Balance, December 31, 2017

 

 

5,125 

 

$

10.46 



 

 

 

 

 

 

At December 31, 2017, there was approximately $59,000 of total unrecognized stock-based compensation expense related to unvested restricted stock and deferred stock awards the Company expects to recognize in 2018.



Long Term Incentive Plan and Award of Deferred Stock

 

Effective March 24, 2016, the Board of Directors of the Company approved a new plan for long-term incentive compensation of the Company’s named executive officers (NEOs) and other Senior Executives called the Canterbury Park Holding Corporation Long Term Incentive Plan (the “LTI Plan”). The LTI Plan authorizes the grant of Long Term Incentive Awards that provide an opportunity to NEOs and other Senior Executives to receive a payment in cash or shares of the Company’s common stock to the extent of achievement at the end of a period greater than one year (the “Performance Period”) as compared to Performance Goals established at the beginning of the Performance Period. The LTI is a sub-plan of the Company’s Stock Plan which authorizes the grant of Deferred Stock awards that represent the right to receive Company common stock if conditions specified in the awards are satisfied.  Further information regarding the LTI Plan is presented under Item 5.02 in the Company’s Report on Form 8-K for March 30, 2016.

 

Effective March 24, 2016, the Board approved 2016 granting opportunities to Company officers and key employees to earn long-term incentive compensation under the LTI Plan. Each officer and key employee was granted an Incentive Award (that was also a Deferred Stock Award under the Stock Plan) which provided an opportunity to receive a payout of shares of the Company’s common stock to the extent of achievement compared to Performance Goals at the end of the period beginning January 1, 2016 and ending December 31, 2018. Pursuant to these awards the Company has reserved 24,000 shares that potentially may be issued under the Deferred Stock Awards. Compensation expense for 2016 was $177,000.  



Effective May 11, 2017, the Board approved 2017 granting opportunities to Company officers and key employees to earn long-term incentive compensation under the LTI Plan. Each officer and key employee was granted an Incentive Award (that was also a Deferred Stock Award under the Stock Plan) which provided an opportunity to receive a payout of shares of the Company’s common stock to the extent of achievement compared to Performance Goals at the end of the period beginning January 1, 2017 and ending December 31, 2019. Pursuant to these awards the Company has reserved 34,554 shares that potentially may be issued under the Deferred Stock Awards. Compensation expense for 2017 was $207,000.  



About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.